Jonathan Quick
Corporate Officer/Principal chez LOGICBIO THERAPEUTICS, INC.
Profil
Jonathan Quick is currently working as the Vice President-Finance at LogicBio Therapeutics, Inc. He previously worked as the Director-Financial Reporting, Planning & Analysis at Celldex Therapeutics, Inc. and as the Director-SEC Reporting & Technical Accounting at Karyopharm Therapeutics, Inc. Mr. Quick completed his undergraduate degree at Providence College.
Postes actifs de Jonathan Quick
| Sociétés | Poste | Début |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Anciens postes connus de Jonathan Quick
| Sociétés | Poste | Fin |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
| CELLDEX THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formation de Jonathan Quick
| Providence College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CELLDEX THERAPEUTICS, INC. | Health Services |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
